This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Pepaxto: A New Peptide-Drug Conjugate for Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
The Annals of pharmacotherapy, 56(8), 951-957
Citation
Jessee, Jeremiah K. (2022). Pepaxto: A New Peptide-Drug Conjugate for Heavily Pretreated Relapsed and Refractory Multiple Myeloma.. The Annals of pharmacotherapy, 56(8), 951-957. https://doi.org/10.1177/10600280211058388